All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Evonik cancels, says gap unbridgeable

The cancellation of the Evonik IPO on Monday wasn’t a surprise for the new issues market but it was a disappointment. It re-opened old wounds – around the efficacy of advisors, the pricing expectations of political issuers and the structure of IPOs. But most of all it left the market bereft of the chance of new deals until after the summer break.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree